1 / 6

Acute Respiratory Distress Syndrome Comparative Analysis Pipeline Review H1 2015

This report gives thorough data on the restorative advancement for Acute Respiratory Distress Syndrome, complete with similar investigation at different stages, therapeutics evaluation by medication target, system of activity (MoA), course of organization (RoA) and particle sort, alongside most recent overhauls, and highlighted news and press discharges. It additionally surveys key players included in the restorative advancement for Acute Respiratory Distress Syndrome and exceptional elements on late-stage and stopped tasks.

jack2222simon
Download Presentation

Acute Respiratory Distress Syndrome Comparative Analysis Pipeline Review H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acute Respiratory Distress Syndrome - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Market Direct Date: 29-May-2015 No. of pages: 86 Single User License: US $2000 Browse more Reports on RespiratoryTherapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/respiratory-therapeutics . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Acute Respiratory Distress Syndrome - Pipeline Review, H1 2015 This report gives thorough data on the restorative advancement for Acute Respiratory Distress Syndrome, complete with similar investigation at different stages, therapeutics evaluation by medication target, system of activity (MoA), course of organization (RoA) and particle sort, alongside most recent overhauls, and highlighted news and press discharges. It additionally surveys key players included in the restorative advancement for Acute Respiratory Distress Syndrome and exceptional elements on late-stage and stopped tasks. The report upgrades choice making abilities and help to make compelling counter procedures to increase upper hand. It reinforces R&D pipelines by recognizing new targets and MOAs to create first-in-class and best-in-class items. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Acute Respiratory Distress Syndrome - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research : BioMarck Pharmaceuticals, Ltd., Faron Pharmaceuticals Oy, FirstString Research, Inc., GlaxoSmithKline plc, Histocell S.L., Mallinckrodt plc, Myelo Therapeutics GmbH, Navigen Pharmaceuticals, Inc., Phylogica Limited, Serendex Pharmaceuticals A/S, Therabron Therapeutics, Inc. and Therametrics holding AG Drugs Profile Discussed in this Research : ALT-836, BIO-10901, CG-367, corticotropin, DasKloster-0141-01, DasKloster-1000-04, dilmapimod, GSK-2586881, GSK-2862277, interferon beta-1a, molgramostim, Monoclonal Antibodies to Inhibit uPA for Infectious Disease and Respiratory Disorders, Monoclonal Antibody to Inhibit E-selectin for Acute Respiratory Distress Syndrome, Myelo-001, perfluorocarbon, PYC-35, PYC-36, PYC-38, PYC-98, S-1229, Slit2Nand some more. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Acute Respiratory Distress Syndrome - Pipeline Review, H1 2015 Scope For Acute Respiratory Distress Syndrome - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Acute Respiratory Distress Syndrome • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Acute Respiratory Distress Syndrome and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Acute Respiratory Distress Syndrome products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Acute Respiratory Distress Syndrome - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Acute Respiratory Distress Syndrome • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Acute Respiratory Distress Syndrome - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related